Celebrating a year of immunotherapy/cell and gene therapy in <i>Blood Advances</i>
Celebrating a year of immunotherapy/cell and gene therapy in Blood AdvancesWith the close of 2024, we wanted to take stock of the eighth year for Blood Advances, which had another banner year.We continue to receive an impressive number of submissions, both cascaded from Blood and submitted directly to Blood Advances.In 2024, Blood Advances' impact factor was 7.4, with the total citations for the journal increasing by an impressive 19% from the previous year.
Authors
- Catherine M. Bollard (ORCID: https://orcid.org/0000-0001-5140-9090)
- Andrew S. Weyrich (ORCID: https://orcid.org/0000-0001-9622-4647)
Publication Details
- Journal
- Blood Advances
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1182/bloodadvances.2024015305
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00